Donor lymphocyte infusion: the use of alloreactive and tumor-reactive lymphocytes for immunotherapy of malignant and nonmalignant diseases in conjunction with allogeneic stem cell transplantation.
about
Immunotherapy of cancer by active vaccination: does allogeneic bone marrow transplantation after non-myeloablative conditioning provide a new option?Visualization of immune response kinetics in full allogeneic chimeras.Revisiting the role of hematopoietic stem cell transplantation in chronic lymphocytic leukemia.Cellular therapy following allogeneic stem-cell transplantation.Donor leukocyte infusions for the treatment of relapsed acute leukemia after allogeneic stem cell transplantation.Inter-strain tissue-infiltrating T cell responses to minor histocompatibility antigens involved in graft-versus-host disease as determined by Vbeta spectratype analysis.Genetically engineered donor T cells to optimize graft-versus-tumor effects across MHC barriers.Current immunotherapy for solid tumors.Retrospective comparison of CD34-selected allogeneic peripheral blood stem cell transplantation followed by CD8-depleted donor lymphocyte infusions with unmanipulated bone marrow transplantation.Stop and go: hematopoietic cell transplantation in the era of chimeric antigen receptor T cells and checkpoint inhibitors.CT60 single-nucleotide polymorphism as a surrogate marker for donor lymphocyte infusion outcome after allogeneic cell transplantation for acute leukemia
P2860
Q35142329-405DD4E1-543B-4F53-B711-B81AF5F72B7FQ35824974-35684BB8-ABBB-44E6-9924-B5D05AEA60D4Q36284521-B0C81FE1-6DAD-445C-BD7B-273EF3051179Q36612643-BA7B78F2-C8CD-45A1-AC12-F5691A504409Q37008223-DE6AE5F7-F606-4F81-85CC-687B715D3BAFQ37036360-6B619BF7-54C6-4CEB-8096-E96756BDFACFQ37416883-A8341883-99D2-4D30-A67D-6E35B0789AAFQ37773274-F1FA94BC-A530-4F92-B82A-89FE2670E25EQ43950281-E9E7F5DB-7E93-41A4-9051-3E3B2398AEEBQ47855599-8904CB82-B68B-4FF2-B999-598927BE71CFQ56898205-E5022AA3-58DA-4B8E-8BA7-D27C974F2734
P2860
Donor lymphocyte infusion: the use of alloreactive and tumor-reactive lymphocytes for immunotherapy of malignant and nonmalignant diseases in conjunction with allogeneic stem cell transplantation.
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Donor lymphocyte infusion: the ...... eic stem cell transplantation.
@ast
Donor lymphocyte infusion: the ...... eic stem cell transplantation.
@en
Donor lymphocyte infusion: the ...... eic stem cell transplantation.
@nl
type
label
Donor lymphocyte infusion: the ...... eic stem cell transplantation.
@ast
Donor lymphocyte infusion: the ...... eic stem cell transplantation.
@en
Donor lymphocyte infusion: the ...... eic stem cell transplantation.
@nl
prefLabel
Donor lymphocyte infusion: the ...... eic stem cell transplantation.
@ast
Donor lymphocyte infusion: the ...... eic stem cell transplantation.
@en
Donor lymphocyte infusion: the ...... eic stem cell transplantation.
@nl
P2093
P1476
Donor lymphocyte infusion: the ...... eic stem cell transplantation.
@en
P2093
Lola Weiss
Shimon Slavin
Shoshana Morecki
P304
P356
10.1089/152581602753658457
P577
2002-04-01T00:00:00Z